Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Mayo Clinic Laboratories, |
RCV002261484 | SCV002541198 | uncertain significance | not provided | 2021-10-05 | criteria provided, single submitter | clinical testing | |
Revvity Omics, |
RCV002261484 | SCV003822723 | uncertain significance | not provided | 2022-08-04 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV003365719 | SCV004065261 | uncertain significance | Inborn genetic diseases | 2023-07-17 | criteria provided, single submitter | clinical testing | The c.3478C>T (p.R1160C) alteration is located in exon 15 (coding exon 15) of the SPTB gene. This alteration results from a C to T substitution at nucleotide position 3478, causing the arginine (R) at amino acid position 1160 to be replaced by a cysteine (C). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |